Welcome to our dedicated page for Danimer Scientific news (Ticker: DNMR), a resource for investors and traders seeking the latest updates and insights on Danimer Scientific stock.
Danimer Scientific Inc (DNMR) is a leading innovator in biodegradable PHA bioplastics derived from renewable plant-based materials. This page provides investors and industry stakeholders with timely updates on the company’s progress in sustainable material science.
Access authoritative updates on DNMR’s financial performance, production advancements, and strategic partnerships. Our curated news collection offers insights into how the company is reshaping industries through compostable plastic alternatives while maintaining commercial viability.
Key updates include quarterly earnings reports, manufacturing facility expansions, new product certifications, and collaborations with global brands transitioning to eco-friendly packaging solutions. All content is verified through primary sources to ensure accuracy.
Bookmark this page for streamlined access to Danimer Scientific’s latest developments in renewable biopolymers. Check regularly for updates on technological breakthroughs and market positioning within the sustainable materials sector.
Danimer Scientific (NYSE: DNMR), a leader in bioplastics, announced its participation in the Credit Suisse 35th Annual Specialties and Basics Conference in New York, NY, on September 14, 2022. The company focuses on sustainable biopolymers that are biodegradable and compostable. With over 430 patents across 20 countries, Danimer aims to reduce environmental pollution from plastic products. Their technology supports various applications, including films, coatings, and fibers, contributing to a cleaner planet.
Danimer Scientific, Inc. (NYSE: DNMR) reported its Q2 2022 financial results, showing revenues of $12.7 million, an 85% increase in PHA-based product sales. However, the company faced a net loss of $30.4 million, coupled with decreased gross profit of $(2.2) million. Adjusted EBITDA also worsened to $(12.9) million from $(2.7) million year-over-year. Danimer maintained a cash balance of $140.4 million and total debt of $264.3 million. Looking ahead, it reaffirms its Adjusted EBITDA outlook for 2022 between $(45) million and $(35) million.
Danimer Scientific (NYSE: DNMR) will announce its second quarter 2022 financial results on August 9, 2022, following market closure. A conference call and webcast will take place at 5:00 p.m. Eastern time to discuss these results and related events. The live presentation will be available on the Company's Investor Relations website, with a replay accessible afterward. Danimer specializes in biodegradable materials, holding over 430 patents globally. The Company remains focused on sustainable biopolymer innovations.
Danimer Scientific (NYSE: DNMR) has been invited to submit a Part II application for a loan guarantee under the U.S. Department of Energy's Title XVII Loan Guarantee Program. This invitation indicates that the project meets technical eligibility requirements. If successful, the funding will support Danimer's Greenfield expansion in Bainbridge and a new plant in the Gulf States region. However, the company warns that there is no guarantee of receiving the loan guarantee, as it depends on the DOE's further evaluation and negotiation process.
Danimer Scientific, Inc. (NYSE: DNMR) reported a 12% increase in total revenues for Q1 2022, reaching $14.7 million, driven by nearly doubling PHA-based product sales. However, gross profit dipped to $(1.3) million from $1.5 million a year earlier. Adjusted EBITDA fell to $(10.6) million due to increased operating costs and R&D expenses. The company projects a challenging year ahead with an expected Adjusted EBITDA range of $(45) million to $(35) million for 2022. Despite these hurdles, Danimer remains focused on scaling production and improving profitability from PHA-based products.
Danimer Scientific (NYSE: DNMR) and Kemira have announced a multi-year license and supply agreement to commercialize biobased barrier coatings for paper and board products. This agreement expands their previous collaboration and targets food and beverage applications across North America, South America, Europe, the Middle East, and Africa. The dispersion barrier market, currently valued at
Danimer Scientific (NYSE: DNMR) will release its Q1 2022 financial results on May 10, 2022, after market close. A conference call is scheduled for 5:00 p.m. Eastern time that same day to discuss the results and recent events. The call will be accessible via the Company’s Investor Relations website or by phone. Danimer is known for creating biodegradable materials and holds over 430 patents in this field. The company emphasizes its commitment to sustainability and innovative bioplastics.
Danimer Scientific (NYSE: DNMR) has appointed Anthony Austin as Chief Human Resource Officer, bringing over 30 years of HR experience from industry giants like PepsiCo and Delta Air Lines. His role will emphasize developing HR processes to support Danimer's growth and expanding manufacturing capacity. Austin's previous position at Bedrock Manufacturing Co. involved leadership in HR strategy and talent management. CEO Stephen E. Croskrey highlighted Austin's expertise as pivotal for scaling operations in response to increasing demand for biodegradable materials.
Danimer Scientific (NYSE: DNMR) reported preliminary financial results for Q4 and 2021, highlighting a 47% revenue increase to $17.7 million in Q4, driven by PHA product sales which grew significantly. However, the company faced a net loss of $12.4 million in Q4, influenced by a $21.3 million non-cash gain from warrant remeasurement. Full year revenues reached $58.7 million, with a net loss of $60.1 million. Management anticipates improved production efficiencies in 2022, especially at its Kentucky facility, which should enhance EBITDA performance moving forward.
